Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin®) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae

被引:28
作者
Bottenfield, GW [1 ]
Burch, DJ [1 ]
Hedrick, JA [1 ]
Schaten, R [1 ]
Rowinski, CA [1 ]
Davies, JT [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Antiinfect Clin Res & Dev, Collegeville, PA 19426 USA
关键词
acute otitis media; drug-resistant Streptococcus pneumoniae; amoxicillin/clavulanate;
D O I
10.1097/00006454-199810000-00041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:963 / 968
页数:6
相关论文
共 13 条